Australia markets closed

Adaptive Biotechnologies Corporation (1HM.MU)

Munich - Munich Delayed price. Currency in EUR
Add to watchlist
3.19700.0000 (0.00%)
At close: 08:04AM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-215,058
-225,250
-200,191
-207,279
-146,227
-
Depreciation & amortisation
22,022
22,231
20,920
13,953
8,472
-
Stock-based compensation
62,535
62,908
55,477
43,251
24,761
-
Change in working capital
-32,014
-46,183
-71,546
-56,816
-40,799
-
Accounts receivable
-11,105
2,032
-22,648
-7,362
2,613
-
Inventory
4,880
-2,838
817
-5,200
-4,994
-
Other working capital
-144,809
-167,021
-200,294
-254,473
-168,486
-
Other non-cash items
11,302
12,392
8,193
6,950
3,337
-
Net cash provided by operating activities
-135,525
-156,324
-183,945
-192,727
-149,683
-
Cash flows from investing activities
Investments in property, plant and equipment
-9,284
-10,697
-16,349
-61,746
-18,803
-
Purchases of investments
-393,941
-429,558
-278,778
-316,544
-694,965
-
Sales/maturities of investments
514,402
569,902
298,032
559,500
596,724
-
Net cash used for investing activities
111,177
129,647
2,905
181,210
-117,044
-
Cash flows from financing activities
Common stock issued
-
-
0
0
272,160
320,850
Other financing activities
-
-
124,375
429
-321
-4,998
Net cash used provided by (used for) financing activities
1,617
2,245
132,265
27,146
293,587
-
Net change in cash
-22,731
-24,432
-48,775
15,629
26,860
-
Cash at beginning of period
96,927
92,428
141,203
125,574
98,714
-
Cash at end of period
74,196
67,996
92,428
141,203
125,574
-
Free cash flow
Operating cash flow
-135,525
-156,324
-183,945
-192,727
-149,683
-
Capital expenditure
-9,284
-10,697
-16,349
-61,746
-18,803
-
Free cash flow
-144,809
-167,021
-200,294
-254,473
-168,486
-